Eu Health Agency Asks For Addition To Astrazeneca S Covid Vaccine Label
The European Medicines Agency (EMA) reviewed cases where six people received the AstraZeneca dose and afterward developed the rare capillary leak disorder. The EMA wants the side effect added to AstraZeneca’s label. Meanwhile, the agency is continuing to review the small number of people who developed heart inflammation after receiving the Pfizer-BioNTech or Moderna vaccine. “Further analysis is needed to determine whether there is a causal link with the vaccines,” the EMA said....